<DOC>
	<DOC>NCT00191867</DOC>
	<brief_summary>The purpose of this study is to assess the Efficacy and Safety of Teriparatide in Japanese Postmenopausal Women with Osteoporosis.</brief_summary>
	<brief_title>Clinical Trial of Teriparatide in Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<criteria>Japanese women with primary osteoporosis Postmenopausal women aged at least 55 years Patients with a high risk for fracture History of metabolic bone disorders other than osteoporosis History of any secondary causes of osteoporosis History of malignant neoplasm within the last 5 years except for superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitively treated Severe or chronically disabling conditions other than osteoporosis</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>